Technical Analysis for WGS - GeneDx Holdings Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 40.44 | 4.30% | 1.67 |
WGS closed up 4.39 percent on Wednesday, September 18, 2024, on 83 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 4.30% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 4.30% | |
| Reversal New Highs Setup | Bullish Swing Setup | 4.30% | |
| New 52 Week High | Strength | 4.30% | |
| Multiple of Ten Bearish | Other | 4.30% | |
| Outside Day | Range Expansion | 4.30% | |
| Overbought Stochastic | Strength | 4.30% | |
| Upper Bollinger Band Touch | Strength | 4.30% | |
| Stochastic Sell Signal | Bearish | 8.88% | |
| NR7 | Range Contraction | 8.88% |
| Alert | Time |
|---|---|
| Reversal New Highs Entry | about 5 hours ago |
| Non-ADX 1,2,3,4 Pullback Entry | about 5 hours ago |
| Rose Above Previous Day's High | about 5 hours ago |
| New 52 Week High | about 5 hours ago |
| Rose Above Upper Bollinger Band | about 5 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/28/2024
GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets.
Sector: Healthcare
Industry: Health Information Services
Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 40.74 |
| 52 Week Low | 1.16 |
| Average Volume | 402,136 |
| 200-Day Moving Average | 17.21 |
| 50-Day Moving Average | 33.36 |
| 20-Day Moving Average | 34.50 |
| 10-Day Moving Average | 35.79 |
| Average True Range | 2.32 |
| RSI (14) | 65.03 |
| ADX | 20.05 |
| +DI | 29.54 |
| -DI | 14.55 |
| Chandelier Exit (Long, 3 ATRs) | 33.79 |
| Chandelier Exit (Short, 3 ATRs) | 35.81 |
| Upper Bollinger Bands | 39.51 |
| Lower Bollinger Band | 29.49 |
| Percent B (%b) | 0.93 |
| BandWidth | 29.07 |
| MACD Line | 1.41 |
| MACD Signal Line | 0.90 |
| MACD Histogram | 0.5094 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 44.85 | ||||
| Resistance 3 (R3) | 44.83 | 42.78 | 43.83 | ||
| Resistance 2 (R2) | 42.78 | 41.24 | 42.79 | 43.49 | |
| Resistance 1 (R1) | 40.78 | 40.28 | 41.78 | 40.80 | 43.16 |
| Pivot Point | 38.73 | 38.73 | 39.24 | 38.74 | 38.73 |
| Support 1 (S1) | 36.73 | 37.19 | 37.73 | 36.75 | 34.38 |
| Support 2 (S2) | 34.68 | 36.23 | 34.69 | 34.05 | |
| Support 3 (S3) | 32.68 | 34.68 | 33.71 | ||
| Support 4 (S4) | 32.70 |
